RA treatment study group: improvement in RA management.
Ward
Michael
M
Building 10 Clinical Research Center, Room 4-1339, National Institute of Arthritis, Musculoskeletal and Skin Diseases, 10 Center Drive, MSC 1468, Bethesda, MD, USA. wardm1@mail.nih.gov
Liang
Matthew H
MH
Burns
Thomas
T
Singh
Gurkirpal
G
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D018501:Antirheumatic Agents; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha; D008727:Methotrexate